Find out more at http://www.respiratorycompromise.org
The mission of the Respiratory Compromise Institute is to prevent suffering and death from Respiratory Compromise by optimizing its recognition, monitoring and management. The Respiratory Compromise Institute is a coalition of healthcare, patient safety, and medical organizations who have come together to bring awareness of clinicians and the public about respiratory compromise.
“Respiratory comp
02/21/2025
Register to attend tomorrow's Zoom webinar at 5pm PT on Exploring Asthma Triggers in SUA with Dr. Matthew Drake, MD, ATSF.
🎟️ https://bit.ly/cts-webinar-feb212025
This is a non-CME event.
Developed by the California Thoracic Society in collaboration with Amgen and AstraZeneca.
12/19/2024
We invite you to watch the welcome speech delivered at RCI's Respiratory Compromise Conference. After the welcome intro, stay tuned for Dr. Wes Ely's virtual presentation on an insightful look at "Preventing Respiratory Catastrophe in the Hospital: Delirium, the 5th vital sign".
https://youtu.be/HWtSqnhLFqc
11/01/2024
Join the California Thoracic Society and GSK via Zoom for their educational webinar & LIVE Q&A tonight @ 5pm PT. 🔗 https://ow.ly/xHNY50TURQS
📚 Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation: Is it the Time for Precision Medicine in COPD?
🗣️ Nicola Hanania, MD, MS | Baylor College of Medicine Professor of Pulmonary Medicine, Director, Airways Clinical Research Center, Member, Vice Chair of Research Group
Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.
This is a non-CME event.
Developed by the California Thoracic Society in collaboration with GSK.
10/31/2024
Join the California Thoracic Society and GSK for tomorrow night's educational webinar & LIVE Q&A on November 1st @ 5pm PT. 🔗 https://ow.ly/xHNY50TURQS
📚 Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation: Is it the Time for Precision Medicine in COPD?
🗣️ Nicola Hanania, MD, MS | Baylor College of Medicine Professor of Pulmonary Medicine, Director, Airways Clinical Research Center, Member, Vice Chair of Research Group
Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.
This is a non-CME event.
Developed by the California Thoracic Society in collaboration with GSK.
10/29/2024
"Almost all children get infected with respiratory syncytial virus (RSV) at least once before they are 2 years old. For most healthy children, RSV is like a cold. But some children get very sick with RSV."
New parents can take preventative measures before their newborn is brought into the world - They just have to know when and how.
Read more - https://www.healthychildren.org/English/health-issues/conditions/chest-lungs/Pages/RSV-When-Its-More-Than-Just-a-Cold.aspx
10/22/2024
Please join the California Thoracic Society for a special educational webinar and LIVE Q&A on October 25th, at 5pm PT.
🔗 https://us06web.zoom.us/webinar/register/WN_hhguooORQa-AQ5WJtcqq4A
Topic: COPD with Type 2 Inflammation: A Spark For Deeper COPD Understanding
Speaker: Joseph E. Khabbaza, MD – Cleveland Clinic Foundation – Respiratory Institute
Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.
Developed by the California Thoracic Society in collaboration with Regeneron Pharmaceuticals Inc.
09/25/2024
Explore new, advanced diagnostic software technologies during an educational webinar & LIVE Q&A with the California Thoracic Society:
🗓️ Friday, September 27th at 5pm PT.
🔗 RSVP TODAY - https://bit.ly/3MLGa9K
Attendees will learn about highly detailed lung ventilation assessments and the precise quantification of lung volumes and other parameters, including areas of the lung with abnormal tissue density, that can provide actionable input for diagnoses.
Additionally, the session will demonstrate how to integrate these technologies to effectively triage patients presenting with unexplained dyspnea.
This is a non-CME event.
Developed by the California Thoracic Society in collaboration with 4DMedical.
09/25/2024
The 3rd week of September is commonly referred to as "asthma peak week".
Here are some helpful tips the American Lung Association is sharing for parents to keep their children safe and healthy all year long.
Read more: https://www.lung.org/blog/asthma-back-to-school-tips
09/23/2024
"AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation"
Read more: https://www.biospace.com/drug-development/lungpacer-medical-announces-pma-submission-for-aeropace-system
09/19/2024
Inspira gains a new U.S. patent approval for their blood oxygenation system. The VORTX system is engineered to oxygenate blood without relying on fibre membranes.
Read more: https://www.medicaldevice-network.com/news/inspira-us-patent-blood-oxygenation/
09/17/2024
"Climate change and air pollution negatively impact the health of patients with respiratory conditions – and yet some treatments used for those same conditions contribute to greenhouse gas emissions. Here, Dr David Lipson, GSK’s Vice President and Clinical Research Head, Respiratory and Immunology R&D, explains why a focus on sustainability in respiratory care is therefore essential – and how GSK is innovating to benefit both patients and the planet."
Read more: https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/
08/09/2024
"Doctors across the world are warning against the rising number of men getting a rare type of lung disease from working with fake marble and granite. In the uK, one death and 11 cases of artificial stone silicosis have been reported recently."
Read more:
https://ow.ly/BSvB50SV340
